Provided by Tiger Trade Technology Pte. Ltd.

Applied Therapeutics Inc.

0.1030
0.0000
Volume:- -
Turnover:- -
Market Cap:14.86M
PE:-0.83
High:0.1030
Open:0.1030
Low:0.1030
Close:0.1030
52wk High:1.50
52wk Low:0.0900
Shares:144.30M
Float Shares:120.21M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1236
EPS(LYR):-0.7570
ROE:-680.47%
ROA:-88.35%
PB:-26.49
PE(LYR):-0.14

Loading ...

Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain

Benzinga_recent_news
·
Nov 14, 2025

Applied Therapeutics Q3 net loss of $19 mln beats expectations

Reuters
·
Nov 13, 2025

Applied Therapeutics Reports Q3 2025 Results and Board Leadership Transition

Reuters
·
Nov 13, 2025

Applied Therapeutics Q3 EPS USD -0.13

THOMSON REUTERS
·
Nov 13, 2025

Applied Therapeutics Inc -in Nov, John Johnson to Step Down as Executive Chairman

THOMSON REUTERS
·
Nov 13, 2025

Top News Today: Stocks Mostly Higher on Government Reopening Hopes

Dow Jones
·
Nov 12, 2025

Top News Today/Canada: Brookfield Renewable Partners to Raise $650 Million

Dow Jones
·
Nov 12, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06, 2025

Applied Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

Applied Therapeutics Says Path Forward Not Determined for Govorestat; Shares Fall Pre-Bell

MT Newswires Live
·
Sep 29, 2025

BRIEF-Applied Therapeutics Provides Update Following Meeting With FDA

Reuters
·
Sep 29, 2025

Applied Therapeutics Inc - Discussions on Govorestat Nda for Cmt-Sord in Q3 2025

THOMSON REUTERS
·
Sep 29, 2025

William Blair Remains a Hold on Applied Therapeutics (APLT)

TIPRANKS
·
Sep 27, 2025

Applied Therapeutics up after details posted for confirmatory govorestat study

TIPRANKS
·
Sep 27, 2025

Applied Therapeutics Inc. Enters $75M Equity Sales Agreement with Cantor Fitzgerald

Reuters
·
Aug 30, 2025

Applied Therapeutics Inc. Considers Reverse Stock Split to Regain Nasdaq Compliance

Reuters
·
Aug 14, 2025

Applied Therapeutics Q2 EPS USD -0.15

THOMSON REUTERS
·
Aug 14, 2025

BRIEF-Applied Therapeutics Says Unaudited Estimate Of Total Stockholders’ Equity As Of June 30 Is About $17.4 Mln

Reuters
·
Aug 12, 2025

Applied Therapeutics Inc - Prelim Unaudited Estimate of Total Stockholders’ Equity as of June 30, 2025 Is About$17.4 Million - SEC Filing

THOMSON REUTERS
·
Aug 12, 2025

Applied Therapeutics Inc. Faces Potential Delisting from Nasdaq; Awaits Decision on Transfer to Nasdaq Capital Market

Reuters
·
Aug 12, 2025